{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:56:53Z","timestamp":1783407413338,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.amjcard.2012.05.049","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T05:15:24Z","timestamp":1340774124000},"page":"1085-1091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction Who Could Benefit from Eplerenone"],"prefix":"10.1016","volume":"110","author":[{"given":"Nikolaos","family":"Kampourides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Tziakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Chalikias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papazoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Maltezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Symeonides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2012.05.049_bib1","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.05.049_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.yjmcc.2009.06.012","article-title":"Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences","volume":"48","author":"Zamilpa","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.049_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases: regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2012.05.049_bib4","doi-asserted-by":"crossref","first-page":"H2216","DOI":"10.1152\/ajpheart.01343.2005","article-title":"Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction","volume":"291","author":"Mukherjee","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.amjcard.2012.05.049_bib5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.lfs.2003.09.042","article-title":"Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice","volume":"74","author":"Tao","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.amjcard.2012.05.049_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0008-6363(00)00029-8","article-title":"Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat","volume":"46","author":"Peterson","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2012.05.049_bib7","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000068375.40887.FA","article-title":"Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling","volume":"107","author":"Wilson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.049_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cardfail.2007.07.006","article-title":"Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function","volume":"13","author":"Orn","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2012.05.049_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/eurheartj\/ehm003","article-title":"Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study","volume":"28","author":"Kelly","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.05.049_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cardfail.2003.11.003","article-title":"Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction","volume":"10","author":"Squire","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2012.05.049_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2005.08.002","article-title":"Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction","volume":"12","author":"Wagner","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2012.05.049_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijcard.2005.01.011","article-title":"Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction","volume":"105","author":"Matsunaga","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.049_bib13","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/eurheartj\/ehn315","article-title":"Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction","volume":"29","author":"Kelly","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2012.05.049_bib14","first-page":"322","article-title":"Ventricular remodelling and tolerance to ischaemia in rabbits with myocardial infarction","volume":"26","author":"Bril","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.amjcard.2012.05.049_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1161\/01.CIR.0000091087.78630.79","article-title":"Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling","volume":"108","author":"Yarbrough","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.049_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.0000085658.98621.49","article-title":"Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?","volume":"108","author":"Jugdutt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.049_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.cardiores.2005.10.002","article-title":"Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window","volume":"69","author":"Vanhoutte","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2012.05.049_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cvr\/cvn333","article-title":"Myocardial repair\/remodelling following infarction: roles of local factors","volume":"81","author":"Sun","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjcard.2012.05.049_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10741-005-2351-3","article-title":"Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure","volume":"10","author":"Zannad","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.amjcard.2012.05.049_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.amjcard.2012.05.049_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1071-9164(03)00578-5","article-title":"Role of a selective aldosterone blocker in mice with chronic heart failure","volume":"10","author":"Wang","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2012.05.049_bib22","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.049_bib23","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2012.05.049_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ahj.2009.04.001","article-title":"Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?","volume":"157","author":"Weir","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2012.05.049_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912015196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914912015196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:24:36Z","timestamp":1757571876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914912015196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002914912015196"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.05.049","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction Who Could Benefit from Eplerenone","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2012.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}